Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medtrum A7+ vs Omnipod in Diabetes
NCT04223973Completed
- Sponsor
- Medtrum
- Start
- Jan 2020
- Primary completion
- Mar 2021
- Countries
- 1
01
Overview
Randomised, open-label trial in diabetes mellitus type 1 (T1D) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Medtrum. Primary endpoint: Estimation of A1C Based on Average Blood Glucose Measured by Continuous Glucose Sensor at Month 3. Started Jan 2020; status: completed.
02
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04223973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04223973.